How do we (meaning you!) improve the low influenza vaccination rate among children who have asthma?
October 4th 2006A report issued late this past summer by the National Foundation for Infectious Diseases (NFID) provides practical strategies and tools to help pediatricians and other health care professionals increase what NFID considers an alarmingly low rate of influenza immunization among children who have asthma—part of an initiative to address immunization barriers and improve parental education about the importance of influenza vaccination for all children with asthma. Influenza vaccination has been shown to reduce morbidity and mortality in this high-risk pediatric population.
NIH's redesigned, relaunched Web site has info for all, while it focuses on child health
October 4th 2006The section of the National Institutes of Health that conducts and supports research on human development, medical rehabilitation, and the health of children, adults, families, and communities, has launched its redesigned Web site with your need and interests in mind. The new National Institute of Child Health and Human Development site, http://www.nichd.nih.gov, provides easy access to information for clinicians and for researchers, patients, and the general public.
Halloween havoc: Allergies, injury have the potential to make the holiday genuinely scary
October 4th 2006Before children get decked out as their favorite cartoon and television characters this Halloween, remind parents that peanuts and milk could be in the candy that young ones receive while trick-or-treating—a situation that could be life-threatening to those who have an allergy to one of these foods.
New momentum on building a medical home for the child with a chronic health problem
October 1st 2006Care provided by a primary care practice that embraces the medical home model is better organized, more accessible, and less stressful to coordinate-so say parents of children who have special health-care needs. Here is a look at how you and your practice benefit from providing family-centered care within the medical home model.
Your role in curbing prescription and OTC drug abuse by adolescents
October 1st 2006Awareness of over-the-counter and prescription drug abuse among adolescents is a first step you can take toward curtailing this worrisome trend. Take care, however, not to risk interfering when patients need these medications.
When children with asthma go swimming, the benefits can be many and long-lasting
October 1st 2006Getting children who have asthma into the water can have remarkable effects on health, the authors' experiences demonstrate. Place a properly structured swimming program on your list of recommendations for these patients, they urge-or put it on your medical community's to-do list.
Wilms tumor: How advances in evaluation and treatment are yielding better outcomes
October 1st 2006A palpable abdominal mass detected during a routine office visit is often the first indication of the presence of this rare but highly treatable tumor of childhood. A child cured of Wilms tumor requires on-going follow-up for potential long-term complications.
New momentum on building a medical home for the child with a chronic health problem
October 1st 2006Care provided by a primary care practice that embraces the medical home model is better organized, more accessible, and less stressful to coordinate-so say parents of children who have special health-care needs. Here is a look at how you and your practice benefit from providing family-centered care within the medical home model.
Getting current on the treatment of inflammatory bowel disease
October 1st 2006Options for treating IBD now include nutritional therapy, probiotics, and biologics. And even therapeutic mainstays, such as steroids and immunomodulators, have undergone improvement. The authors bring you up to date on the newest therapies, the rationale for using them, and their potential for complications.
A new day in preventing meningococcal disease: Sizing up the available vaccines
October 1st 2006The new conjugate vaccine MCV4 promises longer duration of immunity and, perhaps, greater clinical efficacy than the polysaccharide vaccine MPSV4. Questions remain about booster doses, vaccinating young children, and safety.